MENU
BLTE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Belite Bio (BLTE) Earnings Date & Reports
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1)... Show more
A.I. Advisor
published Earnings
BLTE is expected to report earnings to rise 4.29% to -73 cents per share on November 09
Q3'26
Est.
$-0.73
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.30
Q4'25
Beat
by $0.15
Q3'25
Beat
by $0.22
The last earnings report on August 13 showed earnings per share of -69 cents, beating the estimate of -75 cents. With 44.78K shares outstanding, the current market capitalization sits at 6.05B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
41
Web
https://www.belitebio.com